Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/10/2005WO2005105051A1 Improved pullulan capsules
11/10/2005WO2005105050A1 Oral formulation for delivery of poorly absorbed drugs
11/10/2005WO2005105049A2 Orally disintegrating tablets and methods of manufacture
11/10/2005WO2005105048A1 Process for the selective increase of a release rate of an active material from a pharmaceutical composition
11/10/2005WO2005105047A1 Orally disintegrating tablet and method of preparation
11/10/2005WO2005105046A1 Controlled release drug delivery systems and methods for treatment of an eye
11/10/2005WO2005105045A1 Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
11/10/2005WO2005105044A1 Process for making inclusion complex of sulfonylureas having improved aqueous solubility
11/10/2005WO2005105043A2 Pharmaceutical compositions
11/10/2005WO2005105042A1 Buccal, polar and non-polar sprays containing propofol
11/10/2005WO2005105041A2 Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
11/10/2005WO2005105040A2 Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
11/10/2005WO2005105039A1 Solid pharmaceutical form comprising an ltb4 antagonist
11/10/2005WO2005105038A2 A system and a method for producing layered oral dosage forms
11/10/2005WO2005105037A2 Use of a viscoelastic composition for treating increased intraocular pressure
11/10/2005WO2005105036A1 Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
11/10/2005WO2005105035A2 Targeted nanoparticles for drug delivery
11/10/2005WO2005105034A1 Dermally applicable liquid formulations for controlling parasitic arthropods on animals
11/10/2005WO2005105009A1 Wound treatment patch for alleviating pain
11/10/2005WO2005104842A1 Antimicrobial composition
11/10/2005WO2005104768A2 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network
11/10/2005WO2005104712A2 Dpi formulation containing sulfoalkyl ether cyclodextrin
11/10/2005WO2005104648A2 Pegylated nanoparticles
11/10/2005WO2005095390A3 Novel co-precipitate of amorphous rosiglitazone
11/10/2005WO2005089503A3 Cd4-igg2 formulations
11/10/2005WO2005077338A8 Particles for inhalation rapid release properties
11/10/2005WO2005051456A3 Composition and apparatus for transdermal delivery
11/10/2005WO2005051234A3 Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
11/10/2005WO2005042600A3 High molecular weight polymers, devices and method for making and using same
11/10/2005WO2005042142A3 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis
11/10/2005WO2005041924A3 Administration of levodopa and carbidopa
11/10/2005WO2005037256A3 Liquid preparation containing tobramycin
11/10/2005WO2005016319A3 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
11/10/2005WO2004087121A8 Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
11/10/2005WO2004080417A3 Methods and compositions for blocking the calcium cascade
11/10/2005US20050251246 Dilating and support apparatus with disease inhibitors and methods for use
11/10/2005US20050251024 System and method for controlled delivery of a target location within an internal body tissue
11/10/2005US20050250881 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
11/10/2005US20050250817 Pharmaceutical compositions of lipase-containing products, in particular of pancreation
11/10/2005US20050250813 Injectable depot formulation comprising crystals of iloperidone
11/10/2005US20050250764 Solution of an HIV protease inhibitor in a combination of suitable pharmaceutical organic solvents, a surfactant and a bioavailability enhancer; suitable for the preparation of oral solutions for the administration of active drugs and for encapsulation in hard gelatin capsules or soft gelatin capsules
11/10/2005US20050250755 administering to the patient an effective amount of a pharmaceutical formulation comprising:reaction products resulting from oxidation of menthol or an alkene such as geraniol by an oxygen-containing oxidizing agent; a penetrating solvent dimethylsulfoxide; a chelated dye; and an aromatic redox compound
11/10/2005US20050250750 Methods for treating postmenopausal women using ultra-low doses of estrogen
11/10/2005US20050250737 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
11/10/2005US20050250736 Composition and method for treatment of obesity and smoking cessation
11/10/2005US20050250730 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
11/10/2005US20050250710 Antiaging composition
11/10/2005US20050250705 Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
11/10/2005US20050250704 Powder comprising new compositions of oligosaccharides and methods for their preparation
11/10/2005US20050250672 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250175 Bacterial cell wall skeleton component preparaion
11/10/2005US20050249822 Administration of cisplatin by inhalation
11/10/2005US20050249821 Nutritional supplement for treatment of ocular diseases
11/10/2005US20050249814 Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety
11/10/2005US20050249813 Directly compressible tricalcium phosphate
11/10/2005US20050249811 Pharmaceutical compositions for the coordinated delivery of NSAIDs
11/10/2005US20050249810 Film coating for tablets and caplets
11/10/2005US20050249809 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
11/10/2005US20050249808 NSAIDs compositions containing tartaric acid
11/10/2005US20050249807 For injection molding capsule shells; a Eudragit", a lubricant, a dissolution modifying excipient, and optionally a plasticizer, surfactant, or processing agent; multi-component dosage form for versatility of release characteristics
11/10/2005US20050249806 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
11/10/2005US20050249805 Compositions and methods for treating hepatitis C virus (HCV) infection
11/10/2005US20050249803 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
11/10/2005US20050249802 Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
11/10/2005US20050249801 Stabilization of solid drug formulations
11/10/2005US20050249800 System for release in lower gastrointestinal tract
11/10/2005US20050249799 Polymeric drug delivery system for hydrophobic drugs
11/10/2005US20050249798 Gastroretentive drug delivery system comprising an extruded hydratable polymer
11/10/2005US20050249797 Self forming, thermodynamically stable liposomes and their applications
11/10/2005US20050249796 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
11/10/2005US20050249795 Gemcitabine compositions for better drug delivery
11/10/2005US20050249794 Compositions for stimulating cytokine secretion and inducing an immune response
11/10/2005US20050249793 Athletic patch
11/10/2005US20050249792 Active ingredient release system comprising a plaster containing an active ingredient and at least one active ingredient release regulator
11/10/2005US20050249791 Antimicrobial articles
11/10/2005US20050249786 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
11/10/2005US20050249782 Drug delivery device
11/10/2005US20050249778 Carboxylated polysaccharides and method of preparation and use
11/10/2005US20050249774 Drug delivery device is coated with layers of fluid impermeable material forming a cap, film, foam, foil or strip incorporated with a mucoadhesive composition comprising the drug; improved transmucosal delivery
11/10/2005US20050249770 Compositions and methods for treating or preventing inflammatory diseases
11/10/2005US20050249757 Pharmaceutical cream formulations
11/10/2005US20050249756 Use of human prostate cell lines in cancer treatment
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050249721 Compositions and methods for targeted biological delivery of molecular carriers
11/10/2005US20050249716 Oral drug delivery of an enzyme such as erythromycin esterase or beta-lactamase capable of deactivating a beta -lactam, macrolide, or quinolone antibiotic; and a cationic pectinate salt in the form of a bead reticulated by cationic polymer which encloses enzyme; diagnosis; gastrointestinal disorders
11/10/2005US20050249714 Method of using secretin and compositions made therefrom for the treatment of autism and other neurological, behavioral and immunological disorders
11/10/2005US20050249710 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249699 Immunodynamic complexes and methods for using and preparing such complexes
11/10/2005US20050249680 Structures and compositions increasing the stability of peroxide actives
11/10/2005US20050249676 Pullulan capsules
11/10/2005US20050249675 Mucin synthesis inhibitors
11/10/2005US20050249674 aerosol composition comprising a propellant and a first particulate material comprising particles having a median aerodynamic diameter with the range 0.05 to 11 mu m, such as a medicament suitable for pulmonary inhalation, and a second particulate material comprising particles having a median volume
11/10/2005DE20221414U1 Microcapsules useful for immobilizing solids, liquids and/or gases for use in the food, pharmaceutical or chemical industry comprise two mutually immiscible substances forming a phase interface within the capsule and/or in the capsule wall
11/10/2005DE202004020676U1 Storage-stable liquid erythropoietin formulation, for treatment of renal insufficiency, comprises specified amino acids but no preservatives, urea or albumen and is not a reconstituted lyophilizate
11/10/2005DE102004020463A1 Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel Drug delivery system consisting of a medicated plaster and at least one active ingredient release regulator
11/10/2005DE102004020220A1 Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform A process for preparing a secured against abuse, solid dosage form
11/10/2005CA2755954A1 Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists
1 ... 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 ... 2991